FRESENIUS MEDICAL CARE AG (1FME.MI) Fundamental Analysis & Valuation

BIT:1FME • DE0005785802

Current stock price

38.37 EUR
-1.66 (-4.15%)
Last:

This 1FME.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. 1FME.MI Profitability Analysis

1.1 Basic Checks

  • 1FME had positive earnings in the past year.
  • 1FME had a positive operating cash flow in the past year.
  • 1FME had positive earnings in each of the past 5 years.
  • 1FME had a positive operating cash flow in each of the past 5 years.
1FME.MI Yearly Net Income VS EBIT VS OCF VS FCF1FME.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • With a decent Return On Assets value of 3.16%, 1FME is doing good in the industry, outperforming 68.97% of the companies in the same industry.
  • 1FME has a Return On Equity (7.35%) which is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 5.30%, 1FME perfoms like the industry average, outperforming 55.17% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1FME is in line with the industry average of 5.73%.
  • The last Return On Invested Capital (5.30%) for 1FME is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROIC 5.3%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
1FME.MI Yearly ROA, ROE, ROIC1FME.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • 1FME has a better Profit Margin (4.98%) than 79.31% of its industry peers.
  • In the last couple of years the Profit Margin of 1FME has declined.
  • 1FME has a Operating Margin of 9.00%. This is in the better half of the industry: 1FME outperforms 75.86% of its industry peers.
  • In the last couple of years the Operating Margin of 1FME has declined.
  • 1FME's Gross Margin of 25.62% is in line compared to the rest of the industry. 1FME outperforms 58.62% of its industry peers.
  • 1FME's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9%
PM (TTM) 4.98%
GM 25.62%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
1FME.MI Yearly Profit, Operating, Gross Margins1FME.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5

2. 1FME.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1FME is destroying value.
  • The number of shares outstanding for 1FME has been reduced compared to 1 year ago.
  • Compared to 5 years ago, 1FME has less shares outstanding
  • Compared to 1 year ago, 1FME has a worse debt to assets ratio.
1FME.MI Yearly Shares Outstanding1FME.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1FME.MI Yearly Total Debt VS Total Assets1FME.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • 1FME has an Altman-Z score of 1.82. This is not the best score and indicates that 1FME is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 1FME (1.82) is comparable to the rest of the industry.
  • The Debt to FCF ratio of 1FME is 6.19, which is on the high side as it means it would take 1FME, 6.19 years of fcf income to pay off all of its debts.
  • 1FME has a better Debt to FCF ratio (6.19) than 68.97% of its industry peers.
  • 1FME has a Debt/Equity ratio of 0.65. This is a neutral value indicating 1FME is somewhat dependend on debt financing.
  • 1FME has a better Debt to Equity ratio (0.65) than 82.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Altman-Z 1.82
ROIC/WACC0.91
WACC5.82%
1FME.MI Yearly LT Debt VS Equity VS FCF1FME.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that 1FME should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, 1FME is in the better half of the industry, outperforming 72.41% of the companies in the same industry.
  • A Quick Ratio of 0.92 indicates that 1FME may have some problems paying its short term obligations.
  • 1FME has a Quick ratio of 0.92. This is in the better half of the industry: 1FME outperforms 68.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.92
1FME.MI Yearly Current Assets VS Current Liabilites1FME.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

5

3. 1FME.MI Growth Analysis

3.1 Past

  • 1FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.00%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -1.51% on average over the past years.
  • Looking at the last year, 1FME shows a small growth in Revenue. The Revenue has grown by 1.51% in the last year.
  • Measured over the past years, 1FME shows a small growth in Revenue. The Revenue has been growing by 1.91% on average per year.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%

3.2 Future

  • Based on estimates for the next years, 1FME will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.03% on average per year.
  • The Revenue is expected to grow by 3.69% on average over the next years.
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y9.03%
Revenue Next Year-0.21%
Revenue Next 2Y1.76%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1FME.MI Yearly Revenue VS Estimates1FME.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
1FME.MI Yearly EPS VS Estimates1FME.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

6

4. 1FME.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.94, the valuation of 1FME can be described as very reasonable.
  • Based on the Price/Earnings ratio, 1FME is valued cheaper than 89.66% of the companies in the same industry.
  • 1FME's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.77.
  • A Price/Forward Earnings ratio of 9.32 indicates a reasonable valuation of 1FME.
  • Based on the Price/Forward Earnings ratio, 1FME is valued cheaper than 93.10% of the companies in the same industry.
  • 1FME is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.75, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.94
Fwd PE 9.32
1FME.MI Price Earnings VS Forward Price Earnings1FME.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1FME's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1FME is cheaper than 82.76% of the companies in the same industry.
  • 1FME's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1FME is cheaper than 79.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.46
EV/EBITDA 5.98
1FME.MI Per share data1FME.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.59%
EPS Next 3Y5.97%

7

5. 1FME.MI Dividend Analysis

5.1 Amount

  • 1FME has a Yearly Dividend Yield of 3.72%. Purely for dividend investing, there may be better candidates out there.
  • 1FME's Dividend Yield is rather good when compared to the industry average which is at 1.64. 1FME pays more dividend than 93.10% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, 1FME pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.72%

5.2 History

  • The dividend of 1FME has a limited annual growth rate of 4.43%.
Dividend Growth(5Y)4.43%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 43.19% of the earnings are spent on dividend by 1FME. This is a bit on the high side, but may be sustainable.
  • The dividend of 1FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.19%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
1FME.MI Yearly Income VS Free CF VS Dividend1FME.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
1FME.MI Dividend Payout.1FME.MI Dividend Payout, showing the Payout Ratio.1FME.MI Dividend Payout.PayoutRetained Earnings

1FME.MI Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS MEDICAL CARE AG

BIT:1FME (4/2/2026, 7:00:00 PM)

38.37

-1.66 (-4.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength14.19
Industry Growth80.67
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners44.85%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.26B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target45.37 (18.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.72%
Yearly Dividend1.48
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)-1.02%
PT rev (3m)-5.17%
EPS NQ rev (1m)-0.67%
EPS NQ rev (3m)29.57%
EPS NY rev (1m)2.65%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)-0.71%
Revenue NQ rev (3m)-5.93%
Revenue NY rev (1m)-0.95%
Revenue NY rev (3m)-3.02%
Valuation
Industry RankSector Rank
PE 8.94
Fwd PE 9.32
P/S 0.57
P/FCF 6.46
P/OCF 4.2
P/B 0.85
P/tB N/A
EV/EBITDA 5.98
EPS(TTM)4.29
EY11.18%
EPS(NY)4.12
Fwd EY10.73%
FCF(TTM)5.94
FCFY15.49%
OCF(TTM)9.14
OCFY23.81%
SpS66.89
BVpS45.36
TBVpS-5.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number66.1712 (72.46%)
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROCE 7.13%
ROIC 5.3%
ROICexc 5.78%
ROICexgc 16.63%
OM 9%
PM (TTM) 4.98%
GM 25.62%
FCFM 8.88%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Debt/EBITDA 2.64
Cap/Depr 62.47%
Cap/Sales 4.78%
Interest Coverage 4.9
Cash Conversion 82.09%
Profit Quality 178.22%
Current Ratio 1.26
Quick Ratio 0.92
Altman-Z 1.82
F-Score8
WACC5.82%
ROIC/WACC0.91
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year-0.21%
Revenue Next 2Y1.76%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year70.62%
EBIT Next 3Y23.59%
EBIT Next 5Y15.26%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%

FRESENIUS MEDICAL CARE AG / 1FME.MI Fundamental Analysis FAQ

What is the fundamental rating for 1FME stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1FME.MI.


Can you provide the valuation status for FRESENIUS MEDICAL CARE AG?

ChartMill assigns a valuation rating of 5 / 10 to FRESENIUS MEDICAL CARE AG (1FME.MI). This can be considered as Fairly Valued.


What is the profitability of 1FME stock?

FRESENIUS MEDICAL CARE AG (1FME.MI) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for 1FME stock?

The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE AG (1FME.MI) is expected to decline by -4.05% in the next year.


Can you provide the dividend sustainability for 1FME stock?

The dividend rating of FRESENIUS MEDICAL CARE AG (1FME.MI) is 7 / 10 and the dividend payout ratio is 43.19%.